September 29, 2016 2:09 PM ET

Healthcare Equipment and Supplies

Company Overview of Vascular Pathways, Inc.

Company Overview

Vascular Pathways, Inc., a medical device company, focuses on the innovation and optimization of peripheral vascular access devices. It offers AccuCath Intravenous Catheter to sample blood, monitor blood pressure, or administer fluids intravenously. The company was incorporated in 2002 and is based in Naples, Florida. As of July 1, 2015, Vascular Pathways, Inc. operates as a subsidiary of CR Bard Inc.

1847 Trade Center Way

Naples, FL 34109

United States

Founded in 2002

Phone:

239-254-0391

Fax:

239-513-1533

Key Executives for Vascular Pathways, Inc.

Vice President of Clinical Affairs
Vice President of Manufacturing
Vice President of Regulatory Affairs and Quality Assurance
Compensation as of Fiscal Year 2016.

Vascular Pathways, Inc. Key Developments

Vascular Pathways Enters into Contract with Novation for AccuCath Line of Catheters

Vascular Pathways reported a new agreement with Novation for their range of AccuCath Catheters. Vascular Pathways announced that through this new agreement, members and affiliates of VHA Inc., UHC, Children's Hospital Association and Provista will have access at exclusive member rates to its proprietary line of coiled-tip wire guided catheters designed to increase first attempt success, reduce complication rates, extend dwell times, increase patient satisfaction, and lower overall costs to the provider.

Vascular Pathways, Inc. Presents at 2015 Florida Venture Capital Conference, Jan-29-2015

Vascular Pathways, Inc. Presents at 2015 Florida Venture Capital Conference, Jan-29-2015 . Venue: Diplomat Resort & Spa, Hollywood, Florida, United States.

Vascular Pathways, Inc. Names Rudy Mazzocchi Executive Chairman of Board of Directors

Vascular Pathways, Inc. announced the company has appointed Rudy Mazzocchi as Executive Chairman of their Board of Directors. Rudy Mazzocchi has over 25 years of senior management, technology development and financing experience in the medical devices industry. Rudy Mazzocchi has over 25 years of senior management, technology development and financing experience in the medical devices industry. Rudy currently serves as CEO of ELENZA (an Implantable Electro-active Intraocular Lens technology) and previously served as the Interim-CEO of NovaVision Inc.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Vascular Pathways, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.